The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes

The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes

Background: Immune checkpoint inhibitors (ICPIs) are gaining more popularity as a treatment for advanced cancers. However, immune-related adverse events (irAEs) limit their use. We aimed to assess the impact of irAEs and their treatment on clinical and survival outcomes. Materials and Methods: We re...

Full description

Bibliographic Details
Main Authors: Hamzah Abu-Sbeih, Tenglong Tang, Faisal Shaukat Ali, Daniel Hartman Johnson, Wei Qiao, Adi Diab, Yinghong Wang
Format: Article
Language:English
Published: Innovative Healthcare Institute 2018-07-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
adverse events
immune checkpoint inhibitor
immunosuppressive treatment
immunotherapy
impact
survival
toxicities
Online Access:https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_12_18

Internet

https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_12_18

Similar Items